Neuberger Berman Group LLC Novo Cure LTD Transaction History

Neuberger Berman Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$67.99 - $89.57 $140,195 - $184,693	2,062 Added 60.97%	5,444 $414,000
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $215,136 - $341,709	-3,801 Reduced 52.92%	3,382 $235,000
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $432,057 - $607,107	7,183 New	7,183 $565,000
Q2 2020 Aug 13, 2020	SELL	$57.2 - $74.41 $1.2 Million - $1.56 Million	-21,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $1.2 Million - $2.01 Million	21,000 New	21,000 $1.41 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.